Four-factor prothrombin complex concentrates: effectiveness in the reversal of anticoagulation

by Gavva C, Reddy M, Sarode R
Published 2017-04-01

Case Report. Non-Obvious, Post-Traumatic, Life-Threatening Bleeding in Two Elderly Patients

by Carretero Rafael García
Published 2017-04-01

Prothrombin Complex Concentrate in Liver Transplant Surgery: Correction of Therapeutic Anticoagulation and the Coagulopathy of End-Stage Liver Disease: Case Series

by Scarlett V. Marshall, Jordan Noble, Antolin S. Flores
Published 2020-09-01

Emergency intensive care unit pharmacist’s intervention may reduce time to four-factor prothrombin complex concentrate administration: a retrospective study

by Shoichi Imanaka, Tatsuro Kuwabara, Hiroto Ikeda, Yasufumi Miyake, Hiromi Enomoto, Tetsuya Sakamoto, Nobuhiro Yasuno
Published 2020-04-01

Emergency reversal of vitamin-K antagonists related over-anticoagulation: case report and brief overview on the role of Prothrombin Complex Concentrate

by Stefania Angela Di Fusco, Nadia Aspromonte, Stefano Aquilani, Luca Mele, Furio Colivicchi
Published 2013-12-01

Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protoco...

by Christian Ovesen, Jan Purrucker, Christian Gluud, Janus Christian Jakobsen, Hanne Christensen, Thorsten Steiner
Published 2018-10-01

Successful Cerebral Hemorrhage Control with Prothrombin Complex Concentrate in a Patient on Edoxaban Therapy: A Case Report

by Galbiati G
Published 2020-01-01

Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series

by Nina Haagenrud Schultz, Runar Lundblad, Pål Andre Holme
Published 2018-05-01

Efficacy of Prothrombin Complex Concentrate Treatment in Patients with Liver Coagulopathy Who Underwent Various Invasive Hepatobiliary and Gastrointestinal Procedures

by Cosmas Rinaldi A. Lesmana, Lidwina Cahyadinata, Levina S. Pakasi, Laurentius A. Lesmana
Published 2016-06-01

Four-factor prothrombin complex concentrate to reduce allogenic blood product transfusion in patients with major trauma, the PROCOAG trial: study protocol for a randomized multicen...

by Pierre Bouzat, Jean-Luc Bosson, Jean-Stéphane David, Bruno Riou, Jacques Duranteau, Jean-François Payen, on behalf of the PROCOAG study group
Published 2021-09-01

Severe congenital factor X deficiency – An unusual cause of intracranial hemorrhage

by T P Vigneshwaran, A R Mullai Baalaaji, S Ashok Kumar, D Ashwath, Thirugnanam Rajasekar
Published 2018-01-01

Prothrombin Complex Concentrate for Rapid Reversal of Warfarin-induced Anticoagulation and Intracerebral Hemorrhage in Patients Supported by a Left Ventricular Assist Device

by Ayako Takahashi, Tomoko S. Kato, Noboru Oda, Kazuo Komamura, Hideaki Kanzaki, Masaki Asakura, Kazuhiko Hashimura, Kazuo Niwaya, Toshiaki Funatsu, Takeshi Nakatani, Junjiro Kobayashi, Soichiro Kitamura, Toshiaki Shishido, Shigeki Miyata, Jun C. Takahashi, Koji Iihara, Masafumi Kitakaze
Published 2010-09-01

Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases

by E. Mauro, E. Garlatti Costa, A. Zanier, M. Maset, A. Ermacora, M. Ghersetti, P. Casarin
Published 2019-04-01

Reversal of Warfarin-Induced Hemorrhage in the Emergency Department

by Sean O Henderson, Meena Zareh, Andrew J Davis
Published 2011-05-01

Evaluation of anticoagulation re-initiation practices following reversal of factor Xa inhibitors with andexanet alfa or 4F-PCC in patients with major bleeding events

by Awatif Hafiz, Alshaya Abdulrahman I, Katelyn W. Sylvester, Jean M. Connors, Jessica Rimsans
Published 2021-12-01

Three factor Prothrombin Complex Concentrate to Reverse Warfarin Treated Mechanical Circulatory Device Patients Immediately Prior to Heart Transplant

by Sears, Bryan, Cosgrove, Richard
Published 2015

Costs of the management of hemophilia A with inhibitors in Spain

by Santiago Bonanad, María Teresa Álvarez, Ramiro Núñez, José Luis Poveda, Beatriz Gil, Elena Ruíz-Beato, Ana Durán, Yoana Ivanova, Inés Pérez-Román, Almudena González-Domínguez
Published 2021-04-01

The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study

by Nina Haagenrud Schultz, Heidi Glosli, Stine Bjørnsen, Pål Andre Holme
Published 2021-07-01

The outcome of three-factor Prothrombin Complex Concentrate (3F-PCC) in warfarin reversal: A single center retrospective cohort study

by Hock Peng Koh, Nirmala Jagan, Szu Lynn Tay, Jivanraj Nagarajah, Noel Thomas Ross
Published 2020-12-01

Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study

by Raffael P. C. Zamper, Thiago C. Amorim, Veronica N. F. Queiroz, Jordana D. O. Lira, Luiz Guilherme V. Costa, Flavio Takaoka, Nicole P. Juffermans, Ary S. Neto
Published 2018-12-01